Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 3
2008 1
2009 2
2010 5
2011 3
2012 3
2013 3
2014 2
2015 3
2016 3
2017 4
2018 7
2019 12
2020 13
2021 15
2022 19
2023 12

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Ben Khaled N, Seidensticker M, Ricke J, Mayerle J, Oehrle B, Rössler D, Teupser D, Ehmer U, Bitzer M, Waldschmidt D, Fuchs M, Reuken PA, Lange CM, Wege H, Kandulski A, Dechêne A, Venerito M, Berres ML, Luedde T, Kubisch I, Reiter FP, De Toni EN. Ben Khaled N, et al. Among authors: de toni en. Future Oncol. 2022 Apr;18(12):1423-1435. doi: 10.2217/fon-2021-1261. Epub 2022 Jan 27. Future Oncol. 2022. PMID: 35081747 Review.
Reply.
Ben Khaled N, Rössler D, Reiter FP, Mayerle J, Lange CM, Seidensticker M, Guba M, De Toni EN. Ben Khaled N, et al. Among authors: de toni en. Liver Transpl. 2022 May;28(5):897-898. doi: 10.1002/lt.26410. Epub 2022 Mar 10. Liver Transpl. 2022. PMID: 35090084 No abstract available.
Checkpoint Inhibitors.
Heinzerling L, de Toni EN, Schett G, Hundorfean G, Zimmer L. Heinzerling L, et al. Among authors: de toni en. Dtsch Arztebl Int. 2019 Feb 22;116(8):119-126. doi: 10.3238/arztebl.2019.0119. Dtsch Arztebl Int. 2019. PMID: 30940340 Free PMC article. Review.
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma.
Scheiner B, Roessler D, Phen S, Lim M, Pomej K, Pressiani T, Cammarota A, Fründt TW, von Felden J, Schulze K, Himmelsbach V, Finkelmeier F, Deibel A, Siebenhüner AR, Shmanko K, Radu P, Schwacha-Eipper B, Ebert MP, Teufel A, Djanani A, Hucke F, Balcar L, Philipp AB, Hsiehchen D, Venerito M, Sinner F, Trauner M, D'Alessio A, Fulgenzi CAM, Pinato DJ, Peck-Radosavljevic M, Dufour JF, Weinmann A, Kremer AE, Singal AG, De Toni EN, Rimassa L, Pinter M. Scheiner B, et al. Among authors: de toni en. JHEP Rep. 2022 Oct 27;5(1):100620. doi: 10.1016/j.jhepr.2022.100620. eCollection 2023 Jan. JHEP Rep. 2022. PMID: 36578451 Free PMC article.
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.
Lin T, Wang S, Munker S, Jung K, Macías-Rodríguez RU, Ruiz-Margáin A, Schierwagen R, Liu H, Shao C, Fan C, Feng R, Yuan X, Wang S, Wandrer F, Meyer C, Wimmer R, Liebe R, Kroll J, Zhang L, Schiergens T, Ten Dijke P, Teufel A, Marx A, Mertens PR, Wang H, Ebert MPA, Bantel H, N De Toni E, Trebicka J, Dooley S, Shin D, Ding H, Weng HL. Lin T, et al. Among authors: n de toni e. Hepatology. 2022 Feb;75(2):322-337. doi: 10.1002/hep.32119. Epub 2021 Dec 14. Hepatology. 2022. PMID: 34435364
Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma.
Ricke J, Schinner R, Seidensticker M, Gasbarrini A, van Delden OM, Amthauer H, Peynircioglu B, Bargellini I, Iezzi R, De Toni EN, Malfertheiner P, Pech M, Sangro B. Ricke J, et al. Among authors: de toni en. J Hepatol. 2021 Dec;75(6):1387-1396. doi: 10.1016/j.jhep.2021.07.037. Epub 2021 Aug 27. J Hepatol. 2021. PMID: 34454995 Clinical Trial.
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
Ricke J, Klümpen HJ, Amthauer H, Bargellini I, Bartenstein P, de Toni EN, Gasbarrini A, Pech M, Peck-Radosavljevic M, Popovič P, Rosmorduc O, Schott E, Seidensticker M, Verslype C, Sangro B, Malfertheiner P. Ricke J, et al. Among authors: de toni en. J Hepatol. 2019 Dec;71(6):1164-1174. doi: 10.1016/j.jhep.2019.08.006. Epub 2019 Aug 14. J Hepatol. 2019. PMID: 31421157 Clinical Trial.
Current State of Multidisciplinary Treatment in Cholangiocarcinoma.
Ben Khaled N, Jacob S, Rössler D, Bösch F, De Toni EN, Werner J, Ricke J, Mayerle J, Seidensticker M, Schulz C, Fabritius MP. Ben Khaled N, et al. Among authors: de toni en. Dig Dis. 2022;40(5):581-595. doi: 10.1159/000520346. Epub 2021 Oct 25. Dig Dis. 2022. PMID: 34695826 Free article. Review.
Use of checkpoint inhibitors in liver transplant recipients.
Munker S, De Toni EN. Munker S, et al. Among authors: de toni en. United European Gastroenterol J. 2018 Aug;6(7):970-973. doi: 10.1177/2050640618774631. Epub 2018 Apr 30. United European Gastroenterol J. 2018. PMID: 30228883 Free PMC article. Review.
90 results